Evidence map›Paper›PMID 26361349›Full record

ReviewNature reviews. Drug discovery2015

Zebrafish as tools for drug discovery.

Calum A MacRae, Randall T Peterson

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Drug discovery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 549 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
549citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

549 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Europium Metal Complex [Eu(dbm)Chemistry & biodiversity · 2026
    Article
  20. Article

489 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Calum A MacRaeCardiovascular Medicine and Network Medicine Divisions, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Randall T PetersonDepartment of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Funding

Validating promising drug candidates in mammalian models of CN poisoningU54NS079201 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI PETERSON, RANDALL T, PETERSON, RAYMOND J · 2012 to 2016
$12.6M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
Zebrafish Assays Predictive for Cardiotoxicity(RMI)R21GM075946 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MACRAE, CALUM A. · 2005 to 2008
$1.6M
Development of a High-throughput Integrated In Vivo Heart Failure AssayR01HL109264 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MACRAE, CALUM A. · 2012 to 2014
$1.3M
Unbiased screens in zebrafish for new classes of cyanide countermeasureU01NS063563 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MACRAE, CALUM A. · 2008 to 2011
$1.1M
Functional evaluation of GWAS loci for cardiovascular intermediate phenotypesR21HL098938 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MACRAE, CALUM A. · 2009 to 2010
$1.1M
NHLBI NIH HHS R01 HL109264NHLBI NIH HHS R21 HL098938NIGMS NIH HHS R21 GM075946NINDS NIH HHS U01 NS063563NINDS NIH HHS U54 NS079201
6 · The paper itself

Abstract

The zebrafish has become a prominent vertebrate model for disease and has already contributed to several examples of successful phenotype-based drug discovery. For the zebrafish to become useful in drug development more broadly, key hurdles must be overcome, including a more comprehensive elucidation of the similarities and differences between human and zebrafish biology. Recent studies have begun to establish the capabilities and limitations of zebrafish for disease modelling, drug screening, target identification, pharmacology, and toxicology. As our understanding increases and as the technologies for manipulating zebrafish improve, it is hoped that the zebrafish will have a key role in accelerating the emergence of precision medicine.

Indexed as

Drug DiscoveryZebrafishAnimalsDrug Evaluation, PreclinicalEmbryo, NonmammalianHumansModels, AnimalPyrazolesPyrimidinesdorsomorphinPyrazolesPyrimidines

Identifiers

PMID26361349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.